Literature DB >> 8260706

Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.

C Ferri1, M Monti, L La Civita, G Longombardo, F Greco, G Pasero, P Gentilini, S Bombardieri, A L Zignego.   

Abstract

A striking association between hepatitis C virus (HCV) infection and mixed cryoglobulinemia (MC) has been shown; thus, HCV seems to play an important etiopathogenetic role in this lymphoproliferative disorder. Because HCV is both a hepatotropic and lymphotropic virus, this study aimed to investigate the prevalence of HCV infection of peripheral blood mononuclear cells (PBMCs) in a series of 16 patients with type II (IgMk) MC. Antibodies against HCV were detected by commercially available kits (Second Generation Chiron enzyme-linked immunosorbent assay [ELISA] and recombinant-based immunoblot assay [RIBA]), and the presence of HCV RNA was evaluated in both sera and isolated PBMCs using the polymerase chain reaction technique. A previous exposure to HCV was shown by ELISA and confirmed by RIBA in all cases (100%). Moreover, HCV RNA was present in the sera of 8 of 16 patients (50%), whereas its frequency markedly increased (13 of 16 [81%]) when genomic sequences were detected in peripheral lymphocytes. HCV RNA was never detected in the PBMCs of 20 control subjects. These findings showed that HCV infection, alone or in combination with other factors, may be responsible for the clonal B-cell expansion underlying the systemic manifestations of MC, and may explain the appearance of a malignant non-Hodgkin's lymphoma in some subjects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260706

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  Hepatitis C virus infection of human T lymphocytes is mediated by CD5.

Authors:  Mohammed A Sarhan; Tram N Q Pham; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 3.  Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations.

Authors:  A Della Rossa; G Trevisani; S Bombardieri
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Nonhepatic manifestations and combined diseases in HCV infection.

Authors:  S J Hadziyannis
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 5.  Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

Authors:  Clodoveo Ferri; Marco Sebastiani; Dilia Giuggioli; Michele Colaci; Poupak Fallahi; Alessia Piluso; Alessandro Antonelli; Anna Linda Zignego
Journal:  World J Hepatol       Date:  2015-03-27

Review 6.  Cryoglobulins.

Authors:  C Ferri; A L Zignego; S A Pileri
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

Review 7.  Role of hepatitis C virus in B cell lymphoproliferations.

Authors:  Felicia Tucci; Ralf Küppers
Journal:  Virol Sin       Date:  2014-02       Impact factor: 4.327

8.  Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders.

Authors:  Luigi Buonaguro; Annacarmen Petrizzo; Marialina Tornesello; Maria Napolitano; Debora Martorelli; Giuseppe Castello; Gerardo Beneduce; Amalia De Renzo; Oreste Perrella; Luca Romagnoli; Vitor Sousa; Valli De Re; Riccardo Dolcetti; Franco M Buonaguro
Journal:  J Transl Med       Date:  2010-02-19       Impact factor: 5.531

Review 9.  The hepatitis C virus infection as a systemic disease.

Authors:  Anna Linda Zignego; Laura Gragnani; Carlo Giannini; Giacomo Laffi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 10.  Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.

Authors:  Dario Roccatello; Simone Baldovino; Daniela Rossi; Osvaldo Giachino; Morteza Mansouri; Carla Naretto; Debora Di Simone; Simona Francica; Roberto Cavallo; Mirella Alpa; Franca Napoli; Luigi M Sena
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.